---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-110654"
form_type: "8-K"
ticker: "SGMT"
cik: "0001400118"
company_name: "Sagimet Biosciences Inc."
filed_at: "2023-10-23T23:59:59+00:00"
generated_at: "2026-06-09T16:26:44.599253+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Sagimet furnishes updated investor presentation on NASH, acne, cancer pipeline

## Summary
- Filed updated slide deck under Item 7.01 for use in investor meetings.
- Presentation targets metabolic dysfunction therapies for NASH, acne, and cancer.
- No specific financial or clinical data from the deck was disclosed in the 8-K.

## SEC filing metadata
- accession: 0001104659-23-110654
- form_type: 8-K
- ticker: SGMT
- cik: 0001400118
- company_name: Sagimet Biosciences Inc.
- filed_at: 2023-10-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1400118/000110465923110654/0001104659-23-110654-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1400118/000110465923110654/tm2328875d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-110654
- JSON: https://secwatch.observer/filing/0001104659-23-110654.json
- Plain text: https://secwatch.observer/filing/0001104659-23-110654.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.